Quantitative and preliminary clinical assessment of glycohypoxia as an oxygen-unloading defect linking chronic hyperglycemia to low-grade tissue hypoxia in type 2 diabetes: a targeted translational meta-regression with exploratory blood-sample validation.

Authors

Maher Akl, Amr Ahmed

Published in

Frontiers in clinical diabetes and healthcare. Volume 7. Pages 1897413. Epub Jul 15, 2026.

Abstract

Chronic hyperglycemia may impair tissue oxygen delivery by glycating hemoglobin, increasing oxygen affinity, shifting the oxyhemoglobin dissociation curve leftward, and reducing oxygen unloading, a state termed glycohypoxia. This study quantified HbA1c-dependent oxygen-release impairment and tested whether the modeled signal is supported by preliminary clinical validation in type 2 diabetes mellitus (T2DM).
Six human studies (1984-2012; N = 450) reporting HbA1c and oxygen-release metrics were synthesized using random-effects meta-regression. The pooled ΔP50 was translated into oxygen-unloading changes using the Hill equation across microvascular PO₂ values of 20-40 mmHg. In parallel, 90 T2DM patients were stratified by HbA1c into controlled, moderately uncontrolled, and poorly controlled groups for assessment of P50, 2,3-BPG, arterial oxygenation, SpO₂-SaO₂ bias, lactate, and modeled unloading.
Sensitivity-adjusted meta-regression showed ΔP50 = -0.19 mmHg per 1% HbA1c (95% CI: -0.26 to -0.11; P < 0.001; I2 = 45%), predicting 0.5-1.3% less oxygen unloading per 1% HbA1c and 1.5-3.9% cumulatively from HbA1c 6-9%. Clinically, higher HbA1c was associated with lower P50 (27.0 ± 0.5 to 26.2 ± 0.7 mmHg; P < 0.01), reduced 2,3-BPG (4.8 ± 0.4 to 4.2 ± 0.5 µmol/g Hb), increased SpO₂-SaO₂ bias (+0.2 ± 0.4% to +1.8 ± 0.6%; P < 0.01), and higher lactate (1.2 ± 0.3 to 1.9 ± 0.5 mmol/L), despite preserved PaO2.
Quantitative modeling and exploratory clinical validation converged to support glycohypoxia as a measurable oxygen-handling phenotype in T2DM. This pattern may indicate a chronic low-grade functional hypoxic burden that accumulates with glycemic exposure and contributes to T2DM diabetic complications.

PMID:
42529291
Bibliographic data and abstract were imported from PubMed on 17 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.